Results 1 to 10 of about 71,327 (316)

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

open access: yesTherapeutic Advances in Drug Safety, 2023
Background: This research aims to explore and compare the signals of rhabdomyolysis from the use of Proton pump inhibitors (PPIs) using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Ali F. Altebainawi   +4 more
doaj   +2 more sources

Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database

open access: yesScientific Reports, 2023
Rhabdomyolysis is a syndrome potentially fatal and has been associated with selective serotonin reuptake inhibitors (SSRIs) treatment in a few case reports.
Yan Wang   +5 more
doaj   +2 more sources

COVID-19-associated rhabdomyolysis: A scoping review [PDF]

open access: goldInternational Journal of Infectious Diseases, 2023
Objectives: SARS-CoV-2 infection (“COVID-19”) and the hypoxemia that has attended some cases may predispose to rhabdomyolysis. We sought to identify reported cases of COVID-19-associated rhabdomyolysis, examining concurrent risk factors (RFs) and ...
Anna Preger   +3 more
doaj   +2 more sources

Rhabdomyolysis

open access: yesDisease-a-Month, 2020
Rhabdomyolysis is caused by the breakdown and necrosis of muscle tissue and the release of intracellular content into the blood stream. There are multiple and diverse causes of rhabdomyolysis but central to the pathophysiology is the destruction of the sarcolemmal membrane and release of intracellular components into the systemic circulation.
Cabral, Brian Michael I   +3 more
semanticscholar   +6 more sources

Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document

open access: yesTrauma Surgery & Acute Care Open, 2022
Rhabdomyolysis is a clinical condition characterized by destruction of skeletal muscle with release of intracellular contents into the bloodstream.
Christopher P Michetti   +7 more
doaj   +2 more sources

A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management

open access: yesDrug, Healthcare and Patient Safety, 2021
Nisa Safitri,1 Maya Fadila Alaina,1 Dian Ayu Eka Pitaloka,1,2 Rizky Abdulah1,2 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia; 2Center of Excellence in Higher Education for ...
Safitri N   +3 more
doaj   +2 more sources

Rhabdomyolysis due to a hypernatremia hyperosmolar state in trauma brain injured patient: A case report [PDF]

open access: yesTrauma Case Reports
Rhabdomyolysis is a serious entity that can progress to acute renal failure and can be life-threatening. Trauma is the most common cause of rhabdomyolysis. However, other etiologies have been reported, including metabolic disorders.
L. Bennis   +4 more
doaj   +2 more sources

Pediatric rhabdomyolysis: a systematic review and meta-analysis of etiologies, management, and outcomes [PDF]

open access: yesBMC Pediatrics
Background Rhabdomyolysis is a potentially fatal disorder that occurs due to various causes. Therefore, the aim of this meta-analysis was to identify the underlying causes, evaluate the treatment options, and determine the mortality and kidney outcomes ...
Hany A. Zaki   +5 more
doaj   +2 more sources

ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2022
Rhabdomyolysis (RM) is a common complication of exertional heat stroke (EHS) and constitutes a direct cause of death. However, the mechanism underlying RM following EHS remains unclear.
Sixiao He   +8 more
semanticscholar   +1 more source

Omeprazole was safely reused in a rhabdomyolysis patient associated with proton pump inhibitors: A case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Proton pump inhibitors (PPIs) are commonly used in the clinical treatment of abnormal gastric acid secretion and gastric acid related diseases.
Zhen Wang, Jun Shen, Lei Zhang
doaj   +1 more source

Home - About - Disclaimer - Privacy